Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

BZFD vs ABVX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ABVX Captures Overall Composite Edge (42.4 HOLD vs 51.3 HOLD), While BZFD Leads 4–2 on Growth & Valuation Pillars

ABVX Overall Winner 6-Pillar Tally: BZFD 4 – 2 ABVX Matrix Metrics: BZFD 3 – 5 ABVX

As of Nov 20, 2026, Abivax SA (ABVX) captures the overall head-to-head institutional edge over BuzzFeed, Inc. (BZFD) on higher Unified Composite conviction (42.4/100 HOLD vs. 51.3/100 HOLD) after splitting the core matrix 5–3 (led by Growth & Scale, Options & Positioning), while BZFD wins 4–2 across the 6-pillar growth and valuation breakdown. BZFD trades at $0.38 (N/M Forward P/E, -17.7% operating margin) versus ABVX at $73.20 (N/M Forward P/E, -6270.4% operating margin).

  • Composite vs. Pillar Nuance: While BZFD currently prints a higher short-term Unified Composite Score (51.3/100 HOLD vs. ABVX 42.4/100 HOLD), ABVX captures the overall institutional head-to-head verdict (5–3 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (-6270.4% vs. -17.7% operating margin) and revenue trajectory (-6.8% vs. -43.8% YoY).
  • Technical & Structure Timing Caution: BZFD is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 25.3); meanwhile ABVX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BZFD vs ABVX
BZFD NASDAQ
BuzzFeed, Inc. Class A Common Stock
Communications Services, Nec
$0.38
+2.79% 1D
Market Cap $38.1M
TTM Revenue $150M
Forward P/E N/M
Beta / 30D Vol 2.52β · 192% Vol
Unified Composite Score
51.3 / 100 HOLD
Tech 55.0 Fund 52.0 Flow 60.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -16.7%), weak momentum, RSI 25
RSI-14: 25.3 · SMA20: $0.65 · SMA50: $0.91
ABVX NASDAQ Head-to-Head Winner
Abivax SA American Depositary Shares
Pharmaceutical Preparations
$73.20
-9.24% 1D
Market Cap $7.1B
TTM Revenue $4.7M
Forward P/E N/M
Beta / 30D Vol 1.55β · 55% Vol
Unified Composite Score
42.4 / 100 HOLD
Tech 25.0 Fund 38.0 Flow 50.0 Mom 30.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -11.8%), weak momentum, RSI 30
RSI-14: 30.0 · SMA20: $86.08 · SMA50: $91.16

6-Pillar Scorecard Institutional Category Breakdown (BZFD 4 – 2 ABVX)

Columns: Metric · BZFD · ABVX
1. Valuation Multiples BZFD
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 0.5x N/M
2. Growth & Scale ABVX
Revenue Growth (YoY) -43.8% -6.8%
Earnings Growth (YoY) -54.7% +0.0%
TTM Revenue (USD) $150M $4.7M
Market Cap $38.1M $7.1B
3. Profitability & Quality BZFD
Gross Margin 40.5% 100.0%
Operating Margin -17.7% -6270.4%
Net Profit Margin -48.0% 0.0%
Return on Equity (ROE) -123.0% -252.3%
4. Balance Sheet & Cash Flow BZFD
Cash Generation (TTM) -$39M -$292M EBITDA
Cash Flow Margin -26.2% N/A
Net Cash / Leverage $39M Net Debt (1.18x D/E) $5.16 Book/Sh · -252.3% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ABVX
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile 319.8% (50th %ile) 76.9% (<1st %ile)
Put/Call OI Skew N/A Thin ADR Chain
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat BZFD
OpEx & R&D Intensity 58.2% of Rev ($88M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Internet Content & Information Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BZFD (3) vs ABVX (5)
Institutional Metric BZFD ABVX Criterion Row Edge
Market Capitalization
Scale
$38.1M $7.1B Larger Scale ABVX
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
-43.8% -6.8% Higher Growth ABVX
Operating Margin (TTM)
Profitability
-17.7% -6270.4% Higher Margin BZFD
Net Profit Margin
Profitability
-48.0% 0.0% Higher Margin ABVX
Return on Equity (ROE)
Capital Efficiency
-123.0% -252.3% Higher ROE BZFD
52-Week Range Position
Momentum
2% ($0–$2) 12% ($63–$149) Stronger Trend ABVX
Beta / 30D Volatility
Risk Regime
2.52β · 192% Vol 1.55β · 55% Vol Lower Realized Risk ABVX
Unified Institutional Score
Composite Signal
51.3 / 100 (HOLD) 42.4 / 100 (HOLD) Higher Composite BZFD
Trailing 12M Revenue (USD)
Operating Scale
$150M $4.7M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
40.5% 100.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.5x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$39M ($39M Net Debt (1.18x D/E)) -$292M EBITDA ($5.16 Book/Sh · -252.3% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ABVX +42.44 pp
BZFD: -61.31% · ABVX: -18.87%
3M Horizon ABVX +29.81 pp
BZFD: -66.79% · ABVX: -36.98%
6M Horizon ABVX +42.04 pp
BZFD: -82.04% · ABVX: -40.0%
1Y Horizon ABVX +24.82 pp
BZFD: -60.01% · ABVX: -35.19%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BZFD vs ABVX. Trailing 12-month operating profitability (BZFD -17.7% vs ABVX -6270.4%) and valuation multiples (BZFD N/M vs ABVX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

BZFD ADR TTM Benchmark FX-Normalized USD
TTM Revenue$150M
Gross Margin40.5%
Op. Margin-17.7%
ROE / Fwd P/E-123.0% · N/M
ABVX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$4.7M
Gross Margin100.0%
Op. Margin-6270.4%
ROE / Fwd P/E-252.3% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BZFD BREAKDOWN
126d in phase · OBV NEUTRAL
Current IV 319.8%
IV Percentile 50th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact BZFD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ABVX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 76.9%
IV Percentile <1st %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ABVX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BZFD Moat Profile Cyclical / Execution-Driven Positioning
Internet Content & Information Operator
Competes within the Internet Content & Information value chain with $38.1M market capitalization and -17.7% operating margin.
OpEx & R&D Reinvestment 58.2% of Rev ($88M)
90D Engineering Disclosures 0 Published
ABVX Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $7.1B market capitalization and -6270.4% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ BZFD vs ABVX Key Questions & Quantitative Answers

As of Nov 20, 2026, Abivax SA (ABVX) captures the overall head-to-head institutional edge over BuzzFeed, Inc. (BZFD) on higher Unified Composite conviction (42.4/100 HOLD vs. 51.3/100 HOLD) after splitting the core matrix 5–3 (led by Growth & Scale, Options & Positioning), while BZFD wins 4–2 across the 6-pillar growth and valuation breakdown. BZFD trades at $0.38 (N/M Forward P/E, -17.7% operating margin) versus ABVX at $73.20 (N/M Forward P/E, -6270.4% operating margin). Composite vs. Pillar Nuance: While BZFD currently prints a higher short-term Unified Composite Score (51.3/100 HOLD vs. ABVX 42.4/100 HOLD), ABVX captures the overall institutional head-to-head verdict (5–3 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (-6270.4% vs. -17.7% operating margin) and revenue trajectory (-6.8% vs. -43.8% YoY). Technical & Structure Timing Caution: BZFD is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 25.3); meanwhile ABVX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ABVX leads the Growth & Scale pillar: BZFD posts -43.8% YoY revenue growth and -54.7% YoY earnings growth on $150M TTM revenue (40.5% gross margin, -17.7% operating margin), compared with ABVX at -6.8% YoY revenue growth and +0.0% YoY earnings growth on $4.7M TTM revenue (100.0% gross margin, -6270.4% operating margin). On trailing 12-month operating scale, BZFD generates $150M in USD-normalized revenue versus $4.7M for ABVX. In operating R&D and SG&A reinvestment, BZFD deploys 58.2% of Rev ($88M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ABVX.

BZFD screens cheaper on headline valuation multiples. BZFD trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.5x EV/Revenue (-26.2% FCF margin), whereas ABVX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BZFD (-123.0% ROE) versus ABVX (-252.3% ROE) capital efficiency.

In options market volatility and institutional positioning, BZFD carries 319.8% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (2.52β · 192% Vol realized risk). By comparison, ABVX carries 76.9% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.55β · 55% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.